Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-03-01 Exercise |
2021-03-03 8:36 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer |
34,047 | $0 | 464,651 (Direct) |
View |
| 2021-03-01 Tax Withholding |
2021-03-03 8:36 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer |
7,333 | $24.06 | 464,651 (Direct) |
View |
| 2021-03-02 Tax Withholding |
2021-03-03 8:36 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer |
2,844 | $23.25 | 464,651 (Direct) |
View |
| 2021-03-01 Option Award |
2021-03-03 8:36 pm |
N/A 2031-02-28 |
Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer |
149,200 | $0 | 464,651 (Direct) |
View |
| 2021-03-01 Exercise |
2021-03-03 8:32 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Walker Neal President and CEO |
114,403 | $0 | 1,798,389 (Direct) |
View |
| 2021-03-01 Tax Withholding |
2021-03-03 8:32 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Walker Neal President and CEO |
39,792 | $24.06 | 1,798,389 (Direct) |
View |
| 2021-03-02 Tax Withholding |
2021-03-03 8:32 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Walker Neal President and CEO |
7,982 | $23.25 | 1,798,389 (Direct) |
View |
| 2021-03-01 Option Award |
2021-03-03 8:32 pm |
N/A 2031-02-28 |
Aclaris Therapeutics Inc. | ACRS | Walker Neal President and CEO |
328,900 | $0 | 1,798,389 (Direct) |
View |
Ownership |
2021-02-10 6:00 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Foresite Capital Management III LLC Foresite Capital Fund III L.P. Foresite Capital Management IV LLC Foresite Capital Fund IV L.P. Foresite Capital Management V LLC Foresite Capital Fund V L.P. Tananbaum James B. 10% Owner |
0 | $0 | 6,612,181 (Indirect) |
View |
| 2021-02-02 Exercise |
2021-02-03 5:33 pm |
N/A 2028-06-06 |
Aclaris Therapeutics Inc. | ACRS | Mehra Anand Director |
14,632 | $0 | 30,841 (Direct) |
View |
| 2021-02-02 Exercise |
2021-02-03 5:33 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Mehra Anand Director |
8,000 | $18.35 | 30,841 (Direct) |
View |
| 2021-02-02 Exercise |
2021-02-03 5:33 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Mehra Anand Director |
6,632 | $18.32 | 30,841 (Direct) |
View |
| 2021-02-01 Exercise |
2021-02-03 5:29 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer |
3,875 | $0 | 219,064 (Direct) |
View |
| 2021-02-01 Tax Withholding |
2021-02-03 5:29 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer |
1,308 | $21.35 | 219,064 (Direct) |
View |
| 2021-02-01 Exercise |
2021-02-03 5:26 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer |
3,875 | $0 | 130,521 (Direct) |
View |
| 2021-02-01 Tax Withholding |
2021-02-03 5:26 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer |
1,318 | $21.35 | 130,521 (Direct) |
View |
| 2021-02-01 Exercise |
2021-02-03 5:23 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Walker Neal President and CEO |
10,800 | $0 | 1,166,598 (Direct) |
View |
| 2021-02-01 Tax Withholding |
2021-02-03 5:23 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Walker Neal President and CEO |
3,316 | $21.35 | 1,166,598 (Direct) |
View |
| 2020-12-15 Exercise |
2020-12-17 5:08 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Walker Neal President and CEO |
3,034 | $0 | 1,148,314 (Direct) |
View |
| 2020-12-15 Tax Withholding |
2020-12-17 5:08 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Walker Neal President and CEO |
871 | $4.59 | 1,148,314 (Direct) |
View |
| 2020-12-15 Exercise |
2020-12-17 5:07 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer |
1,300 | $0 | 212,622 (Direct) |
View |
| 2020-12-15 Tax Withholding |
2020-12-17 5:07 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer |
370 | $4.59 | 212,622 (Direct) |
View |
| 2020-12-15 Exercise |
2020-12-17 5:06 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer |
1,734 | $0 | 124,089 (Direct) |
View |
| 2020-12-15 Tax Withholding |
2020-12-17 5:06 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer |
498 | $4.59 | 124,089 (Direct) |
View |
| 2020-09-01 Exercise |
2020-09-03 4:23 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Walker Neal President and CEO |
83,092 | $0 | 1,229,243 (Direct) |
View |
| 2020-09-01 Tax Withholding |
2020-09-03 4:23 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Walker Neal President and CEO |
23,872 | $2.33 | 1,229,243 (Direct) |
View |
| 2020-09-01 Option Award |
2020-09-03 4:23 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Walker Neal President and CEO |
83,092 | $0 | 1,229,243 (Direct) |
View |
| 2020-07-02 Exercise |
2020-07-07 7:25 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Gordon David N. Chief Medical Officer |
6,000 | $0 | 99,535 (Direct) |
View |
| 2020-07-02 Tax Withholding |
2020-07-07 7:25 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Gordon David N. Chief Medical Officer |
1,360 | $1.5 | 99,535 (Direct) |
View |
| 2020-06-06 Exercise |
2020-06-08 5:46 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Reasons Bryan M. Director |
7,333 | $0 | 32,709 (Direct) |
View |
| 2020-06-04 Option Award |
2020-06-08 5:46 pm |
N/A 2030-06-03 |
Aclaris Therapeutics Inc. | ACRS | Reasons Bryan M. Director |
16,500 | $0 | 32,709 (Direct) |
View |
| 2020-06-04 Option Award |
2020-06-08 5:45 pm |
N/A 2030-06-03 |
Aclaris Therapeutics Inc. | ACRS | GOWEN MAXINE Director |
16,500 | $0 | 16,500 (Direct) |
View |
| 2020-06-06 Exercise |
2020-06-08 5:31 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director |
7,333 | $0 | 40,391 (Direct) |
View |
| 2020-06-04 Option Award |
2020-06-08 5:31 pm |
N/A 2030-06-03 |
Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director |
16,500 | $0 | 40,391 (Direct) |
View |
| 2020-06-06 Exercise |
2020-06-08 5:30 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Mehra Anand Director |
7,333 | $0 | 32,709 (Direct) |
View |
| 2020-06-04 Option Award |
2020-06-08 5:30 pm |
N/A 2030-06-03 |
Aclaris Therapeutics Inc. | ACRS | Mehra Anand Director |
16,500 | $0 | 32,709 (Direct) |
View |
| 2020-06-06 Exercise |
2020-06-08 5:29 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Humphries William D. Director |
7,333 | $0 | 32,709 (Direct) |
View |
| 2020-06-04 Option Award |
2020-06-08 5:29 pm |
N/A 2030-06-03 |
Aclaris Therapeutics Inc. | ACRS | Humphries William D. Director |
16,500 | $0 | 32,709 (Direct) |
View |
| 2020-06-06 Exercise |
2020-06-08 5:28 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Powell Andrew Kenneth William Director |
7,333 | $0 | 33,209 (Direct) |
View |
| 2020-06-04 Option Award |
2020-06-08 5:28 pm |
N/A 2030-06-03 |
Aclaris Therapeutics Inc. | ACRS | Powell Andrew Kenneth William Director |
16,500 | $0 | 33,209 (Direct) |
View |
| 2020-06-06 Exercise |
2020-06-08 5:27 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director |
7,333 | $0 | 667,164 (Direct) |
View |
| 2020-06-04 Option Award |
2020-06-08 5:27 pm |
N/A 2030-06-03 |
Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director |
16,500 | $0 | 667,164 (Direct) |
View |
| 2020-06-04 Option Award |
2020-06-08 5:24 pm |
N/A 2030-06-03 |
Aclaris Therapeutics Inc. | ACRS | MILANO VINCENT Director |
16,500 | $0 | 16,500 (Direct) |
View |
| 2020-06-01 Exercise |
2020-06-03 4:47 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Walker Neal President and CEO |
73,014 | $0 | 1,159,946 (Direct) |
View |
| 2020-06-01 Tax Withholding |
2020-06-03 4:47 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Walker Neal President and CEO |
20,976 | $1.32 | 1,159,946 (Direct) |
View |
| 2020-06-01 Exercise |
2020-06-03 4:45 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer |
33,188 | $0 | 244,881 (Direct) |
View |
| 2020-06-01 Tax Withholding |
2020-06-03 4:45 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer |
9,451 | $1.32 | 244,881 (Direct) |
View |
| 2020-06-01 Exercise |
2020-06-03 4:43 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Gordon David N. Chief Medical Officer |
87,500 | $0 | 170,395 (Direct) |
View |
| 2020-06-01 Tax Withholding |
2020-06-03 4:43 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Gordon David N. Chief Medical Officer |
24,045 | $1.32 | 170,395 (Direct) |
View |
| 2020-06-01 Exercise |
2020-06-03 4:42 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer |
33,188 | $0 | 156,042 (Direct) |
View |
| 2020-06-01 Tax Withholding |
2020-06-03 4:42 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer |
9,534 | $1.32 | 156,042 (Direct) |
View |